Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-05

FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approves a supplemental application for teriparatide submitted by Prasco Laboratories, establishing a generic version of the osteoporosis therapy. This upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • teriparatide (generic) (teriparatide)

Snippet

SUPPL AP for TERIPARATIDE (TERIPARATIDE)